Long-term results of the HD2000 trial comparing ABVD versus BEACOPP versus COPP-EBV-CAD in untreated patients with advanced hodgkin lymphoma: A study by fondazione Italiana Linfomi

Francesco Merli, Stefano Luminari, Paolo Gobbi, Nicola Cascavilla, Caterina Mammi, Fiorella Ilariucci, Caterina Stelitano, Maurizio Musso, Luca Baldini, Sara Galimberti, F. Angrilli, G. Polimeno, Potito Rosario Scalzulli, Angela Ferrari, Luigi Marcheselli, Massimo Federico

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Long-term results of the HD2000 trial comparing ABVD versus BEACOPP versus COPP-EBV-CAD in untreated patients with advanced hodgkin lymphoma: A study by fondazione Italiana Linfomi'. Together they form a unique fingerprint.

Medicine & Life Sciences